AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ERYTHROPOIETIN
6 registrations across 3 African markets— 5 active
Markets with ERYTHROPOIETIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| WEPOX 5000 Solution For Injection | 🇰🇪Kenya | WOCKHARDT LIMITED | active | Nov 2027 |
| WEPOX 30,000 Solution For Injection | 🇰🇪Kenya | WOCKHARDT LIMITED | active | Nov 2027 |
| EPON 2000IU INJECTION Solution For Injection | 🇰🇪Kenya | Crown Healthcare | active | Jan 2027 |
| EPOFIT_4000 4000IU INJECTION INJECTION | 🇲🇼Malawi | — | expired | Mar 2023 |
| EPOXEM liquid injection | 🇹🇿Tanzania | Advanov Pharma Pvt. Ltd | active | — |
| Repoitin 2000 Solution for injection | 🇹🇿Tanzania | Serum Institute of India Limited | active | — |
ERYTHROPOIETIN in Africa — Regulatory Overview
ERYTHROPOIETIN is registered across 3 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Tanzania, Malawi. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 5 (83%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.